Bank of Communications Pharmaceutical Innovation Stock Fund, ICBC Frontier Pharmaceutical Stock Fund, Guangfa Healthcare Stock Fund, China-Europe Healthcare Hybrid Fund, Shangtou Morgan Healthcare Stock Fund, China Merchants Healthcare Industry Stock Fund, Bosera Healthcare Industry Hybrid Fund, Guangfa CSI Medicine Index lof Fund, China Merchants CSI Biomedical Index lof Fund, E Fund CSI Wonder Biotechnology Index lof Fund.

1. Generally speaking, the top ten funds are referential, but the fund rankings will change, so you can only make reference when investing, and don't invest blindly.

2. The cumulative increase of ICBC Frontier Medical Stock Fund in three years 1.22%. At present, the fund scale is very large, with the fund scale as high as 7.210.70 billion yuan. ICBC Frontier Medical Stock Fund has also been rated as a five-star rating of Shanghai Stock Exchange, and it is also one of the funds with excellent long-term performance, with a cumulative income of 65,438+086.62% within three years.

3. The accumulated income of Guangfa Health Care Stock Fund in recent three years is as high as 65,438+080.38%. It is managed by the fund manager Wu, who has worked for six years with an average annual return of 20.2%. The average annualized rate of return is not very high, and the scale of funds managed is as high as 65.438+0.0602 billion yuan. It is also a medium-and long-term hot-selling fund. The three-year cumulative income of China-Europe medical and health mixed fund is as high as 168.5%. The China-Europe medical and health hybrid fund is managed by Gu Lan, a well-known fund manager. She has been in business for more than five years, and the scale of funds managed is as high as1950.6 billion yuan, which is very huge. It is also a fund with very high long-term performance and income.

1. The accumulated income of Bank of Communications Pharmaceutical Innovation Stock Fund in three years is as high as 193.46%. At present, it is managed by Lou Huiyuan Fund Manager, with a fund scale of 2.787 billion yuan. The Fund was established on March 23, 2007+2065438. It is also the fund with the highest income in the past three years. It has also been rated as a five-star rating by Shanghai Stock Exchange and is one of the long-term outstanding funds. Fang Yuhan, the fund manager, manages Morgan Healthcare Equity Fund. In the process of managing this fund, the term return rate of the fund manager is as high as 136.95438+0%, and the performance is very good. At present, the fund under management is 13438+0 billion yuan. This fund is also one of the five-star rating funds of Shanghai Stock Exchange, and likes to invest in large-cap stocks.